TrialBlood2014
A phase 2 trial of HQK-1001 in HbE-β thalassemia demonstrates HbF induction and reduced anemia.
Poramin Patthamalai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this paperpooled itcites it
TrialBlood2014
Poramin Patthamalai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.